Funding Scrutiny Builds

The $4 million payment reported by The New York Times becomes the center of a congressional and watchdog inquiry into sponsor access, ethics rules and whether health-policy actors received privileged treatment. This would still be a political-governance story, but it could create modest headline risk for named participants and health or food-sector companies tied to MAHA policy.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.